BridgeBio Pharma (BBIO) FCF Margin Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 43,511.00 |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | 6,965.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,965.00 |
| Dec 31, 2025 | 328,424.00 |
| Sep 30, 2025 | 654,887.00 |
| Jun 30, 2025 | -351,891.00 |
| Mar 31, 2025 | -6,709.00 |
| Dec 31, 2024 | 385,634.00 |
| Sep 30, 2024 | -307,119.00 |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 780,036.00 |
| Dec 31, 2023 | -219,232.00 |
| Sep 30, 2023 | 3.64 Mn |
| Jun 30, 2023 | -687,458.00 |
| Mar 31, 2023 | 162,891.00 |
| Dec 31, 2022 | -362,125.00 |
| Sep 30, 2022 | -3.45 Mn |
| Jun 30, 2022 | 106,565.00 |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 7.40 Mn |
| Sep 30, 2021 | -383,465.00 |
| Sep 30, 2020 | -143,840.00 |